ANXA6 and pancreatic neoplasm: These EVs secreted by CAFs, especially those carrying CD9 and ANXA6 on their surface, are taken up by pancreatic cancer cells, subsequently activating the p38 MAPK signaling pathway, leading to increased EMT of the tumor cells (Table 1) [33].